Carbidopa and Levodopa Enteral Suspension and Kisqali (200 MG Dose)
Determining the interaction of Carbidopa and Levodopa Enteral Suspension and Kisqali (200 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Enteral Suspension-Kisqali (400 MG Dose)
- Carbidopa and Levodopa Enteral Suspension-Kisqali (600 MG Dose)
- Carbidopa and Levodopa Enteral Suspension-Kisqali Femara Co-Pack
- Carbidopa and Levodopa Enteral Suspension-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Carbidopa and Levodopa Enteral Suspension-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Carbidopa and Levodopa Enteral Suspension-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Carbidopa and Levodopa Extended-Release Capsules
- Kisqali (200 MG Dose)-Carbidopa and Levodopa Extended-Release Tablets
- Kisqali (200 MG Dose)-Carbidopa and Levodopa ODT
- Kisqali (200 MG Dose)-Carbidopa and Levodopa Orally Disintegrating Tablets
- Kisqali (200 MG Dose)-Carbidopa and levodopa Route Not Applicable
- Kisqali (200 MG Dose)-Carbidopa and Levodopa Tablets